The next earnings report is meaningless - the only source of revenue is Edgemont and they have clearly shown they can't make anything out of this opportunity.
No the only real impact event - potentially for a year or more - will be the new CEO announcement.
If they somehow manage to not only figure out the right type of person that this company needs - but can then somehow convince them to come on board - you could see the stock move up.
If though they pick another person who doesn't have some street credibility - meaning strong pharma management background - this won't go anywhere.
That announcement is probably at least a month away though considering they didn't begin searching until this week.
News 
Market Data 
Discover 
